002390 — Handok Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapValue Trap

Annual income statement for Handok, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	503,612	517,641	543,759	522,741	507,358
Cost of Revenue
Gross Profit	168,391	167,548	173,714	166,348	157,414
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	454,698	487,074	516,038	511,228	523,561
Operating Profit	48,914	30,568	27,722	11,513	-16,202
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	42,128	4,768	7,316	-33,508	-61,661
Provision for Income Taxes
Net Income After Taxes	26,978	3,289	10,596	-28,940	-52,666
Minority Interest
Net Income Before Extraordinary Items
Net Income	26,960	3,295	10,684	-28,797	-52,563
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	26,960	3,295	10,684	-28,797	-52,563
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	986	-59.6	804	-2,045	-3,033
Dividends per Share